A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : BM / bone metastases

[Related PubMed/MEDLINE]
Total Number of Papers: 213
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   BM  (>> Co-occurring Abbreviation)
Long Form:   bone metastases
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Bone metastases in medullary thyroid carcinoma: high morbidity and poor prognosis associated with osteolytic morphology. ART, MTC, SREs
2020 Bone Metastasis: Current State of Play. ---
2020 Variation in the Use of Single- Versus Multifraction Palliative Radiation Therapy for Bone Metastases in Australia. SFRT
2019 A clinical model to predict the risk of synchronous bone metastasis in newly diagnosed colorectal cancer: a population-based study. AUROC, CRC, ROC, SEER
2019 Accelerated Middle Half Body Radiotherapy in Bone Metastases from Prostate Cancer: A Phase I Study (SHARON Project). DLT, MHB, MTD, PCa, RT
2019 Accuracy of iodine density thresholds for the separation of vertebral bone metastases from healthy-appearing trabecular bone in spectral detector computed tomography. HTB, IDM, SDCT, vBMD
2019 Advanced Hepatocellular Carcinoma with Bone Metastases: Prevalence, Associated Factors, and Survival Estimation. HCC, SEER
2019 Analysis of Homogeneous and Heterogeneous Factors for Bone Metastasis in Esophageal Cancer. SEER
2019 BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM study. HRQoL, MBC, VAS
10  2019 Bone metastases and age are associated with earlier dose reductions in metastatic clear-cell renal cell carcinoma patients treated with angiogenesis inhibitors. mccRCC, TKI, VEGFR
11  2019 Bone metastases and skeletal-related events: incidence and prognosis according to histological subtype of lung cancer. NSCLC
12  2019 Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events. BDT, CI, HNC, HR, NPC, OS, RT, SREs
13  2019 Bone Metastases from Thyroid Carcinoma of Follicular Origin: A Single Institutional Experience. IPOLFG, SRE
14  2019 Cause and effect of microenvironmental acidosis on bone metastases. ---
15  2019 Comparison of two multifraction radiotherapy schedules in management of painful bone metastases: A single institution prospective study. RT
16  2019 Cost-effectiveness of standard utilization of zoledronic acid for bone metastases from advanced lung cancer in China. ZA
17  2019 Effects of MRgFUS Treatment on Musculoskeletal Pain: Comparison between Bone Metastasis and Chronic Knee/Lumbar Osteoarthritis. KOA, L-OA, MRgFUS, NRS, PPT
18  2019 Establishing a prediction model for prostate cancer bone metastasis. ALP, bGS, fPSA, PCa, tPSA
19  2019 Female sex is associated with a lower risk of bone metastases and favourable prognosis in non-sex-specific cancers. SEER
20  2019 Impact of the homogeneous and heterogeneous risk factors on the incidence and survival outcome of bone metastasis in NSCLC patients. CSS, NSCLC, OS
21  2019 Improved Survival After Multimodal Approach with 131I Treatment in Patients with Bone Metastases Secondary to Differentiated Thyroid Cancer. DTC, OS
22  2019 LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA AND BONE METASTASES. DTC
23  2019 Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management. BTA
24  2019 More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT. 18 F-FDG, 68Ga, CT, EAU, MRI, PCa, PET/CT, PSA, PSMA, PSMA, SPET, WBS
25  2019 MRI-based texture analysis of the primary tumor for pre-treatment prediction of bone metastases in prostate cancer. DCE T1-w, mpMRI, PCa, ROC, T2W
26  2019 Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer. LCLC, ROC, SCLC
27  2019 Patterns of bone metastases from head and neck squamous cell carcinoma. CT, HNSCC, OS
28  2019 Patterns of bone metastases in newly diagnosed colorectal cancer: a real-world analysis in the SEER database. CRC, SEER
29  2019 Percutaneous consolidation of bone metastases: strategies and techniques. ---
30  2019 Percutaneous management of bone metastases: state of the art, interventional strategies and joint position statement of the Italian College of MSK Radiology (ICoMSKR) and the Italian College of Interventional Radiology (ICIR). ICIR, ICoMSKR
31  2019 Prospective analysis of the association between skeletal-related events and quality of life in patients with advanced lung cancer (CSP-HOR13). ADL, EQ-5D, FACT-G, NSCLC, QOL, SCLC, SREs
32  2019 Retrospective study on the efficacy of bisphosphonates in tyrosine kinase inhibitor-treated patients with non-small cell lung cancer exhibiting bone metastasis. Bps, CI, HR, mBM-OS, mPFS, NSCLC, TKI
33  2019 Risk factors for bone metastasis in patients with primary lung cancer: A systematic review. LC
34  2019 Temporal subtraction of computed tomography images improves detectability of bone metastases by radiology residents. FOM, TS
35  2019 The diagnostic performance of 18F-fluoride PET/CT in bone metastases detection: a meta-analysis. BS, CI, CT, MDP, PET
36  2019 The homogeneous and heterogeneous risk factors for occurrence and prognosis in lung cancer patients with bone metastasis. SEER
37  2019 The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma. HCC, Lnc34a, qRT-PCR
38  2019 The prevalence, associated factors for bone metastases development and prognosis in newly diagnosed ovarian cancer: a large population based real-world study. HR, OC, OR, SEER
39  2019 Thyroid Cancer Bone Metastasis: Survival and Genomic Characteristics of a Large Tertiary Care Cohort. DTC, HIPAA
40  2019 Transactivation of SOX5 by Brachyury promotes breast cancer bone metastasis. Bry, ChIP, EMT
41  2018 A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10). BOMET-QoL-10, EORTC, HRQoL
42  2018 Analysis of curative effect of I125 implantation combined with radiofrequency ablation in treating bone metastases. ---
43  2018 Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter? BPI
44  2018 Bone Metastases in Patients with Neuroendocrine Neoplasm: Frequency and Clinical, Therapeutic, and Prognostic Relevance. ENETS, NEN
45  2018 Bone Metastases Pattern in Newly Diagnosed Metastatic Bladder Cancer: A Population-Based Study. BC, SEER
46  2018 Bone Metastasis in Advanced Breast Cancer: Analysis of Gene Expression Microarray. AUC, ESR1, GATA3
47  2018 Causal Inference Network of Genes Related with Bone Metastasis of Breast Cancer and Osteoblasts Using Causal Bayesian Networks. BC, CBNs, RRs
48  2018 Differentially expressed and survival-related proteins of lung adenocarcinoma with bone metastasis. ENO1, IHC, KMPlotter, LUAD, MALDI-TOF MS, RPLP2
49  2018 Early osteosclerotic changes predict chemotherapy response in non-small-cell lung cancer patients with bone metastases. DCR, NOC, NSCLC, OC, PFS
50  2018 Efficacy of 8 Gy Single Fraction Palliative Radiation Therapy in Painful Bone Metastases: A Single Institution Experience. BPI, CR, PD, PR, SD
51  2018 Incidence of bone metastasis and factors contributing to its development and prognosis in newly diagnosed renal cell carcinoma: a population-based study. CI, RCC
52  2018 Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real world data. BMFI, SREFI, SREs
53  2018 Outcomes of patients with bone metastases from differentiated thyroid cancer. DTC, RAI, Tg
54  2018 Percutaneous image-guided ablation of bone metastases: local tumor control in oligometastatic patients. LPFS
55  2018 Prevention of serious skeletal-related events by interventional radiology techniques in patients with malignant paraganglioma and pheochromocytoma. IR, SRE, TTSRE
56  2018 Prognostic effects of osteoclast inhibitors in extensive stage small cell lung cancer patients with bone metastases. BPs, ES-SCLC, OIs, OS, SREs
57  2018 Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience. DTC, HR, RAI, SRE
58  2018 Solid bone tumors of the spine: Diagnostic performance of apparent diffusion coefficient measured using diffusion-weighted MRI using histology as a reference standard. BPT, CI, DWI, ICC, mADC, MPT, MRI, NEX
59  2018 Systematic review: Incidence, risk factors, survival and treatment of bone metastases from colorectal cancer. CRC, RCT
60  2018 TGF-alpha Overexpression in Breast Cancer Bone Metastasis and Primary Lesions and TGF-alpha Enhancement of Expression of Procancer Metastasis Cytokines in Bone Marrow Mesenchymal Stem Cells. BMSCs
61  2018 The risk factors for bone metastases in patients with colorectal cancer. ALP, CEA, CRC
62  2017 A meta-analysis survey of appropriate bone turnover markers in the detection of bone metastasis in lung cancer. BALP, BTMs, CI, tALP, WMD
63  2017 A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [18F]FMAU-Positron Emission Tomography Imaging of Bone Metastases in Prostate Cancer. BSAP, CRPC, PET, PSA
64  2017 A review of patterns of practice and clinical guidelines in the palliative radiation treatment of uncomplicated bone metastases. MF, SFRT
65  2017 Alkaline phosphatase velocity predicts overall survival and bone metastasis in patients with castration-resistant prostate cancer. ADT, AP, APV, BMFS, CRPC, OS, PSADT
66  2017 Bisphosphonates enhance antitumor effect of EGFR-TKIs in patients with advanced EGFR mutant NSCLC and bone metastases. EGFR, NSCLC, OS, PFS
67  2017 Bone metabolism markers: Indicators of loading dose intravenous ibandronate treatment for bone metastases from breast cancer. BAP, i.v, KPS
68  2017 Dose-escalated radiation therapy is associated with better overall survival in patients with bone metastases from solid tumors: a propensity score-matched study. CI, HR, OS
69  2017 Elevated N-telopeptide as a potential diagnostic marker for bone metastasis in lung cancer: A meta-analysis. CI, sNTx, SROC, uNTx, WMD
70  2017 Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastases. NSCLC, OS, SREs
71  2017 Impact of primary metastatic bone disease in germ cell tumors: results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study. GCT, PFS
72  2017 Intratumoral acidosis fosters cancer-induced bone pain through the activation of the mesenchymal tumor-associated stroma in bone metastasis from breast carcinoma. CIBP
73  2017 MDA-MB-231 breast cancer cells fuel osteoclast metabolism and activity: A new rationale for the pathogenesis of osteolytic bone metastases. MCT4
74  2017 Receptor activator of nuclear factor kappa B (RANK) expression in primary breast cancer correlates with recurrence-free survival and development of bone metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657). BC, HR, OPG, RANK, RANKL, RFS
75  2017 Serum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases. BC, OS, sYB-1, YB-1
76  2017 Skeletal-related events and mortality among men diagnosed with advanced prostate cancer: The impact of alternative measures of radiation to the bone. aHR, PCa, RtB, SREs
77  2017 Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis. HR, IQR, SREs, UC
78  2017 The role of biomarkers in the management of bone-homing malignancies. ---
79  2017 The value of biomarkers in bone metastasis. BTM
80  2016 Bone health in the elderly cancer patient: A SIOG position paper. ---
81  2016 Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma. MTC, SREs
82  2016 Chemotherapy effectively suppresses interleukin-20, receptor activator of nuclear factor kappa-B ligand, and osteoprotegerin levels in patients with lung adenocarcinoma and bone metastasis. ADC, ADC, IL-20, OPG, RANKL
83  2016 Cost-effectiveness of whole-body bone scans in the pre-liver transplant assessment of patients with hepatocellular carcinoma in Southern Brazil. BSs, HCC
84  2016 Does the onset of bone metastasis in sunitinib-treated renal cell carcinoma patients impact the overall survival? mRCC, OS, SRE, TTcP
85  2016 Evaluation of tumor recurrences after radical prostatectomy using 18F-Choline PET/CT and 3T multiparametric MRI without endorectal coil: a single center experience. 18F-CH, CI, LNR, LR, mpMRI, OR, PSA, PSADT, RP
86  2016 Exploiting machine learning for predicting skeletal-related events in cancer patients with bone metastases. BALP, DT, LR, ML, PINP, SREs, SVM, VAS
87  2016 Incidence and predictors of Bone Metastases (BM) and Skeletal-Related Events (SREs) in Small Cell Lung Cancer (SCLC): A Swiss patient cohort. ED, LD, LDH, NSCLC, SCLC, SREs
88  2016 MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma. FDRs, HCC, miRNA, qRT-PCR
89  2016 Optimising TNM Staging of Patients with Prostate Cancer Using WB-MRI. BS, LNM, mpMRI, PCa, PET-CT, WB-MRI
90  2016 Prognostic risk factors in patients with bone metastasis from colorectal cancer. ALP, BMA, CEA, CI, CRC, MST
91  2016 Prognostic significance of intensive local therapy to bone lesions in renal cell carcinoma patients with bone metastasis. BED, mRCC, OS, RT
92  2016 Roles of MicroRNA21 and MicroRNA29a in Regulating Cell Adhesion Related Genes in Bone Metastasis Secondary to Prostate Cancer. BPH, CX3CL1, FFPE, miRNA, mRNA, VCL
93  2016 Sacrum colon-rectal cancer metastasis: microwave ablation for palliative pain treatment. ---
94  2016 Skeletal related events in patients with bone metastasis arising from non-small cell lung cancer. NSCLC, OR, SREs
95  2016 Survival and prognostic factors of patients with renal cell cancer with bone metastasis in the era of targeted therapy: A single-institution analysis. OS, RCC, TT
96  2016 The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases. BC, DFS, OPG, OS, RANK, RANKL
97  2016 Usefulness of dynamic contrast-enhanced magnetic resonance imaging for predicting treatment response to vinorelbine-cisplatin with or without recombinant human endostatin in bone metastasis of non-small cell lung cancer. CT, DCE-MRI, NSCLC, rh-endostatin
98  2016 Whole body MRI (WB-MRI) assessment of metastatic spread in prostate cancer: Therapeutic perspectives on targeted management of oligometastatic disease. EBRT, eLND, LN, PCa, WB-MRI
99  2015 (18)F-FDG PET/CT and pain in metastatic bone cancer. VAS
100  2015 Bone metastases in gastrointestinal cancer. CRC, OSs, PT, SREs